Blog

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 4 of 4

The following is the fourth and final excerpt of the panel discussion, “Future Visions: Are We Heading to Heaven, Hell or Purgatory?,” that Saama Technologies’ Chief Strategy Officer Sagar Anisingaraju participated in on October 28 at MAGI’s Clinical Research Conference – 2019 West, in Las Vegas. The discussion was moderated by Jonathan Zung, Ph.D., member of Saama’s Clinical Board of Advisors and EVP, WCG.

Read More

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 3 of 4

The following is the third installment of the excerpted panel discussion, “Future Visions: Are We Heading to Heaven, Hell or Purgatory?,” that Saama Technologies’ Chief Strategy Officer Sagar Anisingaraju participated in on October 28 at MAGI’s Clinical Research Conference – 2019 West, in Las Vegas. The discussion was moderated by Jonathan Zung, Ph.D., member of Saama’s Clinical Board of Advisors and EVP, WCG.

Read More

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4

Saama Chief Strategy Officer Sagar Anisingaraju participated in a panel discussion titled “Future Visions: Are We Heading to Heaven, Hell or Purgatory?” at MAGI’s Clinical Research Conference – 2019 West. The following is Part 2 of 4 installments of the discussion, moderated by Jonathan Zung, Ph.D., member of Saama’s Clinical Board of Advisors and EVP, WCG.

Read More

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 1 of 4

Saama Chief Strategy Officer Sagar Anisingaraju participated in a panel discussion titled “Future Visions: Are We Heading to Heaven, Hell or Purgatory?” at MAGI’s Clinical Research Conference – 2019 West. The following is Part 1 of 4 installments of the discussion, moderated by Jonathan Zung, Ph.D., member of Saama’s Clinical Board of Advisors and EVP, WCG.

Read More

A Metadata-Driven Approach for Trial Data Management & Analysis for Application in Scalable Clinical Data Lakes

In clinical research and development, data is central to optimizing clinical trials, especially the way the studies are designed and executed. In order to meet the demand of scientists, operations, and project management teams, life sciences companies have evolved their data collection systems with cloud-based solutions. Even though traditional ETL is useful when preparing data…

Read More

Managing Site and Study Performance in Clinical Trials with AI

Clinical trials are extremely expensive and are often fraught with delays. With the increasing complexity of clinical trials, the cost and delays tend to increase and add to the potential risk-factors as well. The pharmaceutical industry is leveraging AI technology to streamline clinical study processes and make them more efficient. It has already made a…

Read More

Streamlining Clinical Trials with AI

A clinical trial involves a set of complex processes, which include writing the protocol, recruiting patients, conducting the study, and culminating in bringing the drug to market. There are many stakeholders involved, in different capacities, to carry out these processes, ensure adherence to regulations, and keep the trial on track. Here are some of the…

Read More

Saama: Walking in IDC’s Footprint, But Forging Our Own Path

Saama recently attended IDC’s 2019 Directions Conference in Santa Clara, CA to hear from the go-to IT industry advisor about how to ensure success in the scaled-up digital economy. The information shared by IDC during the conference was yet another validation of the accuracy of Saama’s strategic vision and data analytics offerings for the life…

Read More

Related Posts